Imperia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 133.53%
(FY 2021)
- Profit 136.26%
(FY 2021)
- Ebitda -47.00%
(FY 2021)
- Net Worth 88.99%
(FY 2021)
- Total Assets 70.41%
(FY 2021)
About Imperia Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ronak Surendra and Doshi Disha serve as directors at the Company.
- CIN/LLPIN
U45100GJ2013PTC120767
- Company No.
248620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Imperia Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ronak Surendra  | Director | 11-Mar-2014 | Current |
| Doshi Disha | Director | 21-Mar-2020 | Current |
Financial Performance of Imperia Life Sciences.
Imperia Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 133.53% increase. The company also saw a substantial improvement in profitability, with a 136.26% increase in profit. The company's net worth Soared by an impressive increase of 88.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imperia Life Sciences?
In 2021, Imperia Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zermatt Pharmaceuticals Private LimitedActive 8 years 1 month
Ronak Surendra and Doshi Disha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Imperia Life Sciences?
Unlock and access historical data on people associated with Imperia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imperia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imperia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
